Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 87500 88882

Blog Standard

Insights Corner: Discover the latest on Antibody Drug Conjugate

Insights Details Month: Aug 25 Tags: Antibody drug Conjugate, Conference, Pre-clinical, Phase 1, Phase 2, Phase 3, US FDA, EMA, Company Profile, Product profile, Deal Analysis, Funding Analysis, Landscape, Oncology, Investment, Immuno-oncology, Global Market Size, Market Trends, Future direction, Lung Cancer, Hematological malignancies, Solid Tumor, Swot Analysis, KOL Profile, Clinical trials Let’s Work Together for […]
Continue Reading

EULAR 2025 Insights Corner: Psoriatic Arthritis Highlights, Competitor Landscape & Biosimilars

Insights Details Month: July 25 Tags: Eular, Conference, Pre-clinical, Phase 1, Phase 2, Phase 3, US FDA, EMA, Company Profile, Product profile, Psoriatic Arthritis, Market Trends, Landscape, Deal Analysis, Funding Analysis, Clinical trials, Biosimilar, Europe, Clinical trials Let’s Work Together for Development Call us directly, submit a sample or email us! Business Address First Floor, […]
Continue Reading

How US Tariffs Will Impact Healthcare & Pharma in 2025: What You Need to Know

Insights Details Month: Jun 25 Tags: Tariff, Conference, USA, China, Import, Export, Tariff impact, Investment, Company Profile, Product profile, Tailwind, Headwind, Landscape, Pfizer, Johnson & Johnson, Roche, BMS, Eli lilly, Novartis, Sanofi, Merck, Abbvie, AstraZeneca Let’s Work Together for Development Call us directly, submit a sample or email us! Business Address First Floor, B-66, Sector […]
Continue Reading

Learning from Trial Failures: Turning Setbacks into Strategic Data Assets

Every company has a “Phase III heartbreak.” The molecule looked perfect-mechanism sound, safety profile strong- but the primary endpoint missed. Most teams bury the data. At Octavus Consulting, we treat it as a gold mine. The Opportunity in Failure Clinical failures hold information about trial design, recruitment, and patient heterogeneity that can redefine the next […]
Continue Reading

Subscribe Newsletter

Sign up to receive notifications about the latest news and events from us!